Search bioRxiv⌕ Search

Biology subjects

Bono, M.

Publications and source records attributed to Bono, M..

2 recordsLinked to original sources

SEC16A/MAG5-mediated ER export shapes ABA receptor homeostasis

The phytohormone abscisic acid (ABA) controls plant adaptation to environmental stress through PYR/PYL/RCAR receptors. Regulated receptor turnover through ubiquitination and endosomal trafficking, including ESCRT-dependent vacuolar degradation, is a major mechanism controlling ABA signalling. However, whether ABA receptor homeostasis is established during the early secretory pathway remains unknown. Using complementary cell biological and biochemical approaches, we define a constitutive early secretory pool of the ABA receptors PYR1 and PYL4 associated with the endoplasmic reticulum (ER) and the Golgi apparatus (GA). Genetic, cell biological and pharmacological analyses reveal that the COPII scaffold protein SEC16A (also known as MAG5) is required for the proper trafficking and homeostasis of this receptor pool. Loss of MAG5 causes intracellular receptor accumulation, impaired trafficking towards late endosomal compartments and enhanced ABA signalling without affecting endogenous ABA accumulation. Together, our findings establish the early secretory pathway as an integral component of the ABA signalling network and demonstrate that MAG5-mediated ER export shapes ABA receptor homeostasis by coordinating receptor trafficking throughout the endomembrane system, revealing the ER as a key regulatory compartment for ABA receptor homeostasis.

plant biology↗

Single-cell multiomic analysis reveals the involvement of Type I interferon-responsive CD8+ T cells in amyloid beta-associated memory loss

Alzheimers disease (AD) is the leading cause of dementia worldwide, but there are limited therapeutic options and no current cure. While the involvement of microglia in AD has been highly appreciated, the role of other innate and adaptive immune cells remains largely unknown, partly due to their scarcity and heterogeneity. This study aimed to study non-microglial immune cells in wild type and AD-transgenic mouse brains across different ages. Our results uncovered the presence of a unique CD8+ T cell population that were selectively increased in aging AD mouse brains, here referred to as "disease-associated T cells (DATs)". These DATs were found to express an elevated tissue-resident memory and Type I interferon-responsive gene signature. Further analysis of aged AD mouse brains showed that these CD8+ T cells were not present in peripheral or meningeal tissues. Preventing CD8+ T cell development in AD-transgenic mice via genetic deletion of beta-2 microglobulin (B2m) led to a reduction of amyloid-{beta} plaque formation in aged mice, and improved memory in AD-transgenic mice as early as four months of age. The integration of transcriptomic and epigenomic profiles at the single-cell level revealed potential transcription factors that reshape the regulomes of CD8+ T cells. These findings highlight a critical role for DATs in the progression of AD and provide a new avenue for treatment.

immunology↗